Showing 1 to 2 of 2 results


Clopidogrel Superior to Aspirin in Preventing Cardiovascular Events
A new study published in the Lancet reveals that clopidogrel, a blood thinner, is more effective than aspirin in preventing major cardiovascular events in patients with coronary artery disease (CAD), without increasing the risk of bleeding.
Clopidogrel Superior to Aspirin in Preventing Cardiovascular Events
A new study published in the Lancet reveals that clopidogrel, a blood thinner, is more effective than aspirin in preventing major cardiovascular events in patients with coronary artery disease (CAD), without increasing the risk of bleeding.
Progress
40% Bias Score

BMS and Sanofi Pay $700 Million to Settle Plavix Lawsuit
Bristol Myers Squibb and three Sanofi subsidiaries will pay $700 million to Hawaii to settle a decade-long lawsuit alleging they withheld information about Plavix's limited effectiveness, particularly for approximately 30% of patients, including a significant portion of Hawaii's population.

BMS and Sanofi Pay $700 Million to Settle Plavix Lawsuit
Bristol Myers Squibb and three Sanofi subsidiaries will pay $700 million to Hawaii to settle a decade-long lawsuit alleging they withheld information about Plavix's limited effectiveness, particularly for approximately 30% of patients, including a significant portion of Hawaii's population.
Progress
40% Bias Score
Showing 1 to 2 of 2 results